DRKS00027927招募中未知

A multicenter randomized controlled trial to evaluate overall morbidity after total minimally invasive esophagectomy versus hybrid esophagectomy - MICkey

Klinik für Allgemeine, Viszeral- und Transplantationschirurgie Universitätsklinikum Tübingen0 个研究点目标入组 152 人开始时间: 2022年7月4日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.) Malignant tumor of the thoracic esophagus or the esophagogastric junction considered to be resectable with curative intent via esophagectomy by means of an abdominal and right thoracic approach (Ivor-Lewis procedure) irrespective of neoadjuvant therapy
•2.) Suitability of patient for MIN-E and HYBRID-E
•3.) Age = 18 years
•4.) Ability of subject to understand character and individual consequences of the clinical trial
•Written informed consent

•1.) Distant metastases
•2.) Tumor localization above the azygos vein
•3.) History of supraumbilical laparotomy or right thoracotomy within last three years
•4.) American Society of Anesthesiologists (ASA)>3
•5.) Hepatic cirrhosis Child B/C
•6.) Participation in another interventional trial with interference of intervention and/or outcome of this trial
•7.) Expected lack of compliance or language problems
•8.) Participation in another intervention-trial with interference of intervention and outcome of this study

发起方

Klinik für Allgemeine, Viszeral- und Transplantationschirurgie Universitätsklinikum Tübingen